文献速递认知障碍与痴呆

认知正常成人阿尔茨海默病生物标志物变化顺序:横断面研究

Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
PubMed 文献 · Neurology · 2020-09-01

该研究整合8项研究的3,284名18至101岁认知正常个体的脑脊液指标、PiB PET分子影像、MRI脑结构与临床认知结局横断面数据,估计各标志物加速变化的年龄(变化点)并比较。结果显示脑脊液Aβ42与Aβ42/Aβ40比值变化最早,PiB SUVR次之,脑脊液Tau/Ptau与MRI海马体积、皮层厚度约在60岁附近,认知复合评分最晚。

要点

  • 脑脊液Aβ42变化点约48.28岁,Aβ42/Aβ40比值约46.02岁,早于其他标志物。
  • PiB SUVR变化点约54.47岁,脑脊液Tau与Ptau约60岁,认知复合评分约62.41岁。
  • Aβ42与Aβ42/Aβ40比值变化点显著早于Tau、Ptau、MRI标志物及认知复合评分。

核心结论

  • 研究结果支持临床前AD中淀粉样蛋白早期变化的假说,并提示神经元损伤与神经退行性标志物的变化与认知下降时间接近。

研究设计与样本

  • 横断面研究,整合8项研究、共3,284名18至101岁认知正常个体的脑脊液分析物、[11C]苯并噻唑示踪剂PiB PET、MRI脑结构及临床/认知结局数据。
  • 估计并比较各标志物出现加速变化的年龄(变化点)。

主要发现

  • 脑脊液Aβ42变化点为48.28岁,Aβ42/Aβ40比值变化点为46.02岁。
  • PiB平均皮层SUVR变化点为54.47岁。
  • 脑脊液总Tau与苏氨酸181磷酸化Tau(Ptau)变化点约为60岁,与MRI海马体积和皮层厚度相似。
  • 认知复合评分变化点为62.41岁。
  • 脑脊液Aβ42与Aβ42/Aβ40比值变化点虽与PiB SUVR无显著差异,但显著早于脑脊液Tau、Ptau、MRI标志物及认知复合评分。

临床怎么用

  • 在认知正常成人中解读AD生物标志物时,可参考淀粉样蛋白标志物早于神经退行性标志物与认知下降的变化顺序。
  • 判读脑脊液Aβ42/Aβ40比值、PiB SUVR、Tau/Ptau及MRI标志物时,应结合年龄理解其异常出现的先后。
  • 认知正常人群的AD生物标志物结果需按变化点所对应的年龄阶段进行纵向随访评估。

局限性

  • 原文为横断面研究,变化点由年龄横断面数据估计,不能直接反映个体纵向轨迹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the ordering of changes in Alzheimer disease (AD) biomarkers among cognitively normal individuals. METHODS: Cross-sectional data, including CSF analytes, molecular imaging of cerebral fibrillar β-amyloid (Aβ) with PET using the [11C] benzothiazole tracer Pittsburgh compound B (PiB), MRI-based brain structures, and clinical/cognitive outcomes harmonized from 8 studies, collectively involving 3,284 cognitively normal individuals 18 to 101 years of age, were analyzed. The age at which each marker exhibited an accelerated change (called the change point) was estimated and compared across the markers. RESULTS: Accelerated changes in CSF Aβ1-42 (Aβ42) occurred at 48.28 years of age and in Aβ42/Aβ40 ratio at 46.02 years, followed by PiB mean cortical standardized uptake value ratio (SUVR) with a change point at 54.47 years. CSF total tau (Tau) and tau phosphorylated at threonine 181 (Ptau) had a change point at ≈60 years, similar to those for MRI hippocampal volume and cortical thickness. The change point for a cognitive composite occurred at 62.41 years. The change points for CSF Aβ42 and Aβ42/Aβ40 ratio, albeit not significantly different from that for PiB SUVR, occurred significantly earlier than that for CSF Tau, Ptau, MRI markers, and the cognitive composite. Adjusted analyses confirmed that accelerated changes in CSF Tau, Ptau, MRI markers, and the cognitive composite occurred at ages not significantly different from each other. CONCLUSIONS: Our findings support the hypothesized early changes of amyloid in preclinical AD and suggest that changes in neuronal injury and neurodegeneration markers occur close in time to cognitive decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Luo J, Agboola F, Grant E, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. 2020. PMID: 32873693. doi:10.1212/WNL.0000000000010747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。